Investigating Generation of Antibodies against the Lipid Nanoparticle Vector Following COVID-19 Vaccination with an mRNA Vaccine
Molecular Pharmaceutics · 2023
DOI: 10.1021/acs.molpharmaceut.2c01036 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2023. Verfasst von Rasmus Münter und 10 weiteren Autor:innen. Beteiligte Einrichtung: Biotherapeutic Engineering and Drug Targeting, Department of Health Technology, Technical University of Denmark (DTU), Kgs. Lyngby 2800, Denmark. Hauptthemen laut MEDLINE: COVID-19, Nanoparticles, Hypersensitivity. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: Svend Andersen Fonden, Novo Nordisk Fonden, Carlsbergfondet.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biotherapeutic Engineering and Drug Targeting, Department of Health Technology, Technical University of Denmark (DTU), Kgs. Lyngby 2800, Denmark.
- Department of Clinical Immunology, Copenhagen University Hospital, Rigshospitalet, Copenhagen 2100, Denmark.
- Department of Cardiology, Copenhagen University Hospital Herlev and Gentofte, Copenhagen 2100, Denmark.
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen 2200, Denmark.
- Viru-immunology Research Unit, Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen 2100, Denmark.
- Laboratory of Molecular Medicine, Department of Clinical Immunology, Section 7631, Copenhagen University Hospital, Rigshospitalet, Copenhagen 2100, Denmark.
ORCID-Profile: Rasmus Münter, Jannik B Larsen
Förderung
- Svend Andersen Fonden
- Novo Nordisk Fonden
- Carlsbergfondet
Zitieren
APA
Münter, R., Sørensen, E., Hasselbalch, R. B., Christensen, E., Nielsen, S. D., Garred, P., Ostrowski, S. R., Bundgaard, H., Iversen, K. K., Andresen, T. L., & Larsen, J. B. (2023). Investigating Generation of Antibodies against the Lipid Nanoparticle Vector Following COVID-19 Vaccination with an mRNA Vaccine. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.2c01036
Vancouver
Münter R, Sørensen E, Hasselbalch RB, Christensen E, Nielsen SD, Garred P, et al. Investigating Generation of Antibodies against the Lipid Nanoparticle Vector Following COVID-19 Vaccination with an mRNA Vaccine. Molecular Pharmaceutics. 2023. doi:10.1021/acs.molpharmaceut.2c01036
BibTeX
@article{Mnter2023,
author = {Münter, Rasmus and Sørensen, Erik and Hasselbalch, Rasmus B and Christensen, Esben and Nielsen, Susanne D and Garred, Peter and Ostrowski, Sisse R and Bundgaard, Henning and Iversen, Kasper K and Andresen, Thomas L and Larsen, Jannik B},
title = {Investigating Generation of Antibodies against the Lipid Nanoparticle Vector Following COVID-19 Vaccination with an mRNA Vaccine},
journal = {Molecular Pharmaceutics},
year = {2023},
doi = {10.1021/acs.molpharmaceut.2c01036}
}
EUVIMED